Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
0.4313
+0.0048 (1.13%)
At close: Mar 28, 2025, 4:00 PM
0.3440
-0.0873 (-20.24%)
Pre-market: Mar 31, 2025, 9:04 AM EDT
Enzo Biochem Market Cap
Enzo Biochem has a market cap or net worth of $22.60 million as of March 31, 2025. Its market cap has decreased by -64.12% in one year.
Market Cap
22.60M
Enterprise Value
-14.56M
1-Year Change
-64.12%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since December 1, 1998, Enzo Biochem's market cap has decreased from $389.70M to $22.60M, a decrease of -94.20%. That is a compound annual growth rate of -10.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 22.60M | -39.41% |
| Dec 31, 2024 | 37.30M | -46.87% |
| Dec 29, 2023 | 70.20M | 0.72% |
| Dec 30, 2022 | 69.70M | -55.21% |
| Dec 31, 2021 | 155.60M | 28.91% |
| Dec 31, 2020 | 120.70M | -3.52% |
| Dec 31, 2019 | 125.10M | -4.65% |
| Dec 31, 2018 | 131.20M | -65.69% |
| Dec 29, 2017 | 382.40M | 19.02% |
| Dec 30, 2016 | 321.30M | 54.99% |
| Dec 31, 2015 | 207.30M | 4.33% |
| Dec 31, 2014 | 198.70M | 64.62% |
| Dec 31, 2013 | 120.70M | 13.76% |
| Dec 31, 2012 | 106.10M | 22.66% |
| Dec 30, 2011 | 86.50M | -57.07% |
| Dec 31, 2010 | 201.50M | -1.08% |
| Dec 31, 2009 | 203.70M | 11.43% |
| Dec 31, 2008 | 182.80M | -60.92% |
| Dec 31, 2007 | 467.80M | 1.54% |
| Dec 29, 2006 | 460.70M | 15.23% |
| Dec 30, 2005 | 399.80M | -36.66% |
| Dec 31, 2004 | 631.20M | 11.76% |
| Dec 31, 2003 | 564.80M | 28.54% |
| Dec 31, 2002 | 439.40M | -40.36% |
| Dec 31, 2001 | 736.80M | -5.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |